Gabapentin
Product Images NDC 68788-8546

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68788-8546). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 01)

Chemical structure diagram of Gabapentin showing its cyclohexane ring and attached functional groups—an amino group (CH2NH2) and a carboxyl group (CH2CO2H).*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 02)

A line graph comparing mean pain scores over 8 weeks for placebo and Gabapentin 3600 mg/day groups. The x-axis represents weeks, divided into a 4-week dose titration period and a 4-week fixed dose period, while the y-axis shows mean pain scores ranging from 0 to 10. Gabapentin group scores decrease noticeably compared to placebo.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 03)

Line graph showing mean pain score over a 7-week period comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks with baseline and 7 weeks labeled, while the y-axis shows the mean pain score from 0 to 10. Data includes a 3-week dose titration period followed by a 4-week fixed dose period, illustrating changes in pain scores over time for each group.*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 04)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' displaying data for two studies. It compares placebo (PBO) versus Gabapentin (GBP) at different dosages (3600 mg, 1800 mg, and 2400 mg) with proportions ranging approximately from 12% to 34%, annotated with statistical significance indicators (p < 0.01 and p < 0.001).*

FDA Label Image

Image (6827ca69 0e15 4426 94ae Cb5f94bdbe65 05)

A scatter plot chart showing percentage difference on the y-axis and daily dose in mg on the x-axis, comparing three studies labeled as Study a, Study b, and Study c. Data points for daily doses of 600, 900, 1200, and 1800 mg are presented with varying percentage differences for each study.*

FDA Label Image

Gabapentin Capsules Usp 400mg Cv (6827ca69 0e15 4426 94ae Cb5f94bdbe65 08)

Packaging label for Gabapentin Capsules, USP 400mg (CV), a generic for Neurontin. The label shows the product strength, dosage form, a caution about federal law prohibiting drug transfer, storage instructions, manufacturer as Graviti Pharmaceuticals, and directions sections in English and Spanish. The labeler is Preferred Pharmaceuticals Inc. with a location in Anaheim, CA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.